Genetic Stratification to Identify Risk Groups for Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Stratification by genetic risk factors for Alzheimer’s disease (AD) may help identify groups with the greatest disease risk. Biological changes that cause late-onset AD are likely to occur years, if not decades prior to diagnosis. Here, we select a subset of the Generation Scotland: Scottish Family Health Study cohort in a likely preclinical age-range of 60–70 years (subset n = 3,495 with cognitive and genetic data). We test for cognitive differences by polygenic risk scores for AD. The polygenic scores are constructed using all available SNPs, excluding those within a 500 kb distance of the APOE locus. Additive and multiplicative effects of APOE status on these associations are investigated. Small memory decrements were observed in those with high polygenic risk scores for AD (standardized beta –0.04, p = 0.020). These associations were independent of APOE status. There was no difference in AD polygenic scores across APOE haplotypes ( p = 0.72). Individuals with high compared to low polygenic risk scores for AD (top and bottom 5% of the distribution) show cognitive decrements, albeit much smaller than for APOE ɛ4 ɛ4 compared to ɛ3 ɛ3 individuals (2.3 versus 3.5 fewer points on the processing speed test, and 1.8 versus 2.8 fewer points on the memory test). Polygenic risk scores for AD may help identify older individuals at greatest risk of cognitive decline and preclinical AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“Keywords: Alzheimer’s disease, apolipoprotein E, cognitive function, genetics, polygenic traits”
BackgroundDefeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Escott-Price, V., Bellenguez, C., Wang, L.-S., Choi, S.-H., Harold, D., Jones, L., Holmans, P., Gerrish, A., Vedernikov, A., Richards, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094661 · Cited by 1,398
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Lunnon, K., Smith, R., Hannon, E., De Jager, P. L., Srivastava, G., Volta, M., Troakes, C., Al-Sarraj, S., Burrage, J., Macdonald, R., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3782 · Cited by 574
Common polygenic variation enhances risk prediction for Alzheimer’s disease
Escott-Price, V., Sims, R., Bannister, C., Harold, D., Vronskaya, M., Majounie, E., Badarinarayan, N., GERAD/PERADES, consortia, I., Morgan, K., et al. (2015) · Brain · doi:10.1093/brain/awv268 · Cited by 414
Smith, B. H., Campbell, A., Linksted, P., Fitzpatrick, B., Jackson, C., Kerr, S. M., Deary, I. J., MacIntyre, D. J., Campbell, H., McGilchrist, M., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys084 · Cited by 401 · cited 2×
“110 A full description of the cohort and the data col111 lected have been reported elsewhere [13, 14] and at 112 http://www.”
BackgroundMethodSelf-citationApolipoprotein E in Alzheimer's Disease: An Update
Yu, J.-T., Tan, L., & Hardy, J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014300 · Cited by 394 · cited 1×
“The apolipoprotein gene, APOE, which is involved in lipid transportation, confers the greatest known genetic risk of AD [5, 6].”
BackgroundMETASTROKE Consortium, I. C. F. B. P. G., Hagenaars, S. P., SpiroMeta Consortium, CHARGE Consortium Pulmonary Group, C. C. A. A. L. G., Harris, S. E., Davies, G., Hill, W. D., Liewald, D. C. M., Ritchie, S. J., Marioni, R. E., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.225 · Cited by 350
Self-citationEisenberg, D. T. A., Kuzawa, C. W., & Hayes, M. G. (2010) · American Journal of Physical Anthropology · doi:10.1002/ajpa.21298 · Cited by 231 · cited 1×
“The 4 allele has a frequency in the general pop43 ulation of around 15% [8], implying that just over 44”
Background
Cited by
Analysis of the B cell receptor repertoire in six immune-mediated diseases
Bashford-Rogers, R. J. M., Bergamaschi, L., McKinney, E. F., Pombal, D. C., Mescia, F., Lee, J. C., Thomas, D. C., Flint, S. M., Kellam, P., Jayne, D. R. W., et al. (2019) · Nature · doi:10.1038/s41586-019-1595-3 · Cited by 284
Kauppi, K., Fan, C. C., McEvoy, L. K., Holland, D., Tan, C. H., Chen, C.-H., Andreassen, O. A., Desikan, R. S., Dale, A. M., & Initiative, T. A. D. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00260 · Cited by 60
“…risk scores beyond APOE based on case-control data from large-scale genome-wide association studies (GWAS) (Lambert et al., 2013), and found that genetic variants associated with elevated AD risk also influence brain structure (Sabuncu et al., 2012) and cognitive function (Marioni et al., 2017).”
BackgroundGao, X. R., Chiariglione, M., Qin, K., Nuytemans, K., Scharre, D. W., Li, Y.-J., & Martin, E. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-27551-1 · Cited by 45
Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review
Huq, A. J., Fransquet, P., Laws, S. M., Ryan, J., Sebra, R., Masters, C. L., Winship, I. M., James, P. A., & Lacaze, P. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.05.011 · Cited by 35
“[13] No difference in PRS across APOE genotypes 60–70 yrs PRS N/A—APOE ε4/ε4 data not given Unable to calculate”
BackgroundNetwork Dynamics‐based Subtyping of Alzheimer's Disease With Microglial Genetic Risk Factors
Choi, J. H., Lee, J., Kang, U., Chang, H., & Cho, K.-H. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01583-9 · Cited by 7
Metadata
- Authors
- Marioni, R. E., Campbell, A., Hagenaars, S. P., Nagy, R., Amador, C., Hayward, C., Porteous, D. J., Visscher, P. M., & Deary, I. J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2017-02-10
- Volume
- 57
- Issue
- 1
- Pages
- 275-283
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2586290911
- Cited by
- 30
- References
- 9
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic Stratification to Identify Risk Groups for Alzheimer’s Disease. https://app.cochat.ai/papers/10.3233/jad-161070
- The paper
- Marioni, R. E., Campbell, A., Hagenaars, S. P., Nagy, R., Amador, C., Hayward, C., Porteous, D. J., Visscher, P. M., & Deary, I. J. (2017). Genetic Stratification to Identify Risk Groups for Alzheimer’s Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-161070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.